CME/CE – Conference Highlights: CROI 2019
This course discusses the key findings of six studies presented at the 2019 annual Conference on...
antiretroviral therapy
Conference Highlights: CROI 2019
New research was presented at CROI 2019, the annual Conference on Retroviruses and Opportunistic...
Examining Why HIV Patients Discontinue ART
Discontinuation of antiretroviral therapy (ART) among patients with HIV has been found to lead to...
Screening for HIV
In the United States, an estimated 1.2 million people are infected with HIV, and about 50,000 new...
Guidelines: Improving Retention & Treatment Adherence in HIV
Patient adherence to antiretroviral therapy (ART) is one of the most important factors associated with successful HIV outcomes. Following a diagnosis, timely entry into HIV medical care is essential to the provision of ART....
IDWeek 2012: EMRs Improve Treatment of ARV Recipients
The Particulars: Antiretroviral (ARV) medication errors may lead to toxicity and could decrease the efficacy of therapy over time. Such errors can also lead to the development of viral mutations to current ARV therapy and limit...
Making the Case for Earlier ART in HIV
The benefits of antiretroviral therapy (ART) during acute and early HIV infection remain unproven, despite several years of investigations into the topic. Studies have yielded conflicting results, with many having too few...
International AIDS Society 2012 Meeting
New research was presented at AIDS 2012, the 19th International AIDS Conference, from July 22-27 in Washington, DC. The features below highlight just some of the studies that emerged from the conference. Multiple Benefits With...
Managing HIV: A Call to Action for Primary Care Physicians
Click here to listen to a podcast of Dr. Wong discussing the growing need of support for HIV care....
HIV: From Prevention to Care and Treatment
The incidence of HIV in the United States has remained stable over the last 15 years, while the...
Conference Highlights: CROI 2012
CROI 2012, the annual Conference on Retroviruses and Opportunistic Infections, took place from March 5-8 in Seattle. The features below highlight just some of the studies that emerged from the conference. Can Circumcision...
Managing HCV/HIV Coinfection
According to national estimates, about 15% to 30% of people with HIV in the United States are coinfected with hepatitis C virus (HCV). Reports also show that as many as 90% of those with HIV secondary to injection drug use are...
